0001140361-22-009254.txt : 20220311 0001140361-22-009254.hdr.sgml : 20220311 20220311210616 ACCESSION NUMBER: 0001140361-22-009254 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220311 FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Apelian David CENTRAL INDEX KEY: 0001546842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 22734908 MAIL ADDRESS: STREET 1: C/O ACHILLION PHARMACEUTICALS, INC STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 4 1 form4.xml FORM 4 X0306 4 2022-03-11 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001546842 Apelian David C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306 true Common Stock 2022-03-11 4 A 0 6000 0 A 16000 D Stock Option (Right to Buy) 5.1 2022-03-11 4 A 0 12000 0 A 2032-03-10 Common Stock 12000 12000 D Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 11, 2022. The option vests in equal monthly installments over 12 months measured from March 11, 2022 subject to Reporting Person's continuous service status as of each such date. /s/ Sriram Ryali, Attorney-in-Fact 2022-03-11